Stock NEUN NEUROGENESIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Neurogenesis, Inc.

Equities

NEUN

US64124F3010

Market Closed - OTC Markets
Other stock markets
 14:49:23 2024-06-12 EDT 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Neurogenesis, Inc. 0.00% 0.00%
2023 Neurogenesis, Inc. Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome CI
2021 Neurogene Inc. and University of Edinburgh Announces Research Collaboration to Advance Next Generation Gene Therapies CI

Managers

Managers TitleAgeSince
Albert H. Bieser CHM
 Chairman - 97-12-31
Karen Coady AUD
 Comptroller/Controller/Auditor - -
Paul Brown SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Albert H. Bieser CHM
 Chairman - 97-12-31
Karen Coady AUD
 Comptroller/Controller/Auditor - -

Company contact information

NeuroGenesis, Inc.

1241 Butler Road

77573, League City

+

http://www.neurogenesis.com
address Neurogenesis, Inc.(NEUN)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. NEUN Stock
  4. Company Neurogenesis, Inc.